Andagao, Cheryl V.
HRN: 06-28-78 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2023
CO-AMOXICLAV 625MG (TAB)
04/28/2023
05/05/2023
ORAL
625mg/tab
TID
UTI
Waiting Final Action
05/03/2023
CO-AMOXICLAV 625MG (TAB)
05/03/2023
05/06/2023
PO
625mg
BID
UTI
Waiting Final Action